Evaluation of Respiratory Parameters in Patients With Upper Limb Lymphedema

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

82 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-20

Study Completion Date

2024-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study is to assess disease severity, respiratory muscle strength, respiratory functions, pectoralis minor muscle shortening, functionality, and quality of life (QoL) in patients with upper limb lymphedema (ULL), and to compare these findings with healthy controls.The disease severity was assessed using the Stillwell classification system; respiratory muscle strength was measured through maximum inspiratory and expiratory intraoral pressures (MIP, MEP, respectively); respiratory functions were evaluated with a spirometer; pectoralis minor muscle shortening was measured with a tape measure; functionality was assessed using the Disabilities of the Arm, Shoulder and Hand (DASH); and QoL was evaluated with the Lymphedema Quality of Life Questionnaire - Arm (LYMQOL-Arm).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Inspiratory Muscle Training on Lymphedema

NCT06521268

Lymphedema

ACTIVE_NOT_RECRUITING NA

High Intensity vs Low Intensity Resistive Exercise In Patient With Upper Extremity Lymphedema

NCT05650372

Lymphedema

COMPLETED NA

Inspiratory and Calf Muscles Training in Patients With Leg Lymphedema

NCT05609526

Lymphedema of Leg Lymphedema Exercise

UNKNOWN NA

Evaluation of Pulmonary Function in Burn Injury

NCT03780218

Burns

COMPLETED

Comparison of Respiratory Muscle, Pain, Functional Performance and Cognitive Status in Obstructive Lung Diseases

NCT04048408

Pain, Chronic Obstructive Pulmonary Disease Cognitive Impairment +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study had a cross-sectional observational study design. The participants were divided into two groups, patients with ULL in Group 1; the healthy individuals were included in Group 2. All assessments for both groups were performed by two different physiotherapists.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphedema of Upper Limb

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

patients with upper limb lymphedema

Assessments of respiratory parameters

Intervention Type OTHER

respiratory muscle strength, respiratory function test

Group 2

healthy individuals

Assessments of respiratory parameters

Intervention Type OTHER

respiratory muscle strength, respiratory function test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessments of respiratory parameters

respiratory muscle strength, respiratory function test

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 25-65 years with secondary, unilateral upper limb lymphedema in Phase 2 of the protection stage,
* wearing compression garments,
* who have not received manual lymph drainage (MLD) therapy in the last 3 months
* along with healthy controls of a similar age who volunteered to participate.

Exclusion Criteria

* being in Phase 1 of lymphedema treatment (the edema-reducing phase),
* being classified as NYHA Class III and/or IV according to the New York Heart Association classification system,
* having a chronic respiratory disease,
* presence of active infection (such as lymphangitis or cellulitis), or undergoing radiotherapy/chemotherapy due to breast cancer.

Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes